360 related articles for article (PubMed ID: 29765101)
1. Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
Dawes BE; Kalveram B; Ikegami T; Juelich T; Smith JK; Zhang L; Park A; Lee B; Komeno T; Furuta Y; Freiberg AN
Sci Rep; 2018 May; 8(1):7604. PubMed ID: 29765101
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate-dependent enhancement of henipavirus infection.
Mathieu C; Dhondt KP; Châlons M; Mély S; Raoul H; Negre D; Cosset FL; Gerlier D; Vivès RR; Horvat B
mBio; 2015 Mar; 6(2):e02427. PubMed ID: 25759505
[TBL] [Abstract][Full Text] [Related]
3. A treatment for and vaccine against the deadly Hendra and Nipah viruses.
Broder CC; Xu K; Nikolov DB; Zhu Z; Dimitrov DS; Middleton D; Pallister J; Geisbert TW; Bossart KN; Wang LF
Antiviral Res; 2013 Oct; 100(1):8-13. PubMed ID: 23838047
[TBL] [Abstract][Full Text] [Related]
4. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
5. Developments towards effective treatments for Nipah and Hendra virus infection.
Bossart KN; Broder CC
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
[TBL] [Abstract][Full Text] [Related]
6. Hendra and Nipah infection: emerging paramyxoviruses.
Aljofan M
Virus Res; 2013 Nov; 177(2):119-26. PubMed ID: 23954578
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.
Jochmans D; van Nieuwkoop S; Smits SL; Neyts J; Fouchier RA; van den Hoogen BG
Antimicrob Agents Chemother; 2016 Aug; 60(8):4620-9. PubMed ID: 27185803
[TBL] [Abstract][Full Text] [Related]
8. Hendra and Nipah viruses: pathogenesis and therapeutics.
Eaton BT; Broder CC; Wang LF
Curr Mol Med; 2005 Dec; 5(8):805-16. PubMed ID: 16375714
[TBL] [Abstract][Full Text] [Related]
9. Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation.
Sugai A; Sato H; Takayama I; Yoneda M; Kai C
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835499
[TBL] [Abstract][Full Text] [Related]
10. Simulating henipavirus multicycle replication in a screening assay leads to identification of a promising candidate for therapy.
Porotto M; Orefice G; Yokoyama CC; Mungall BA; Realubit R; Sganga ML; Aljofan M; Whitt M; Glickman F; Moscona A
J Virol; 2009 May; 83(10):5148-55. PubMed ID: 19264786
[TBL] [Abstract][Full Text] [Related]
11. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses.
Delang L; Abdelnabi R; Neyts J
Antiviral Res; 2018 May; 153():85-94. PubMed ID: 29524445
[TBL] [Abstract][Full Text] [Related]
12. Hendra and nipah infection: pathology, models and potential therapies.
Vigant F; Lee B
Infect Disord Drug Targets; 2011 Jun; 11(3):315-36. PubMed ID: 21488828
[TBL] [Abstract][Full Text] [Related]
13. Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection.
Freiberg AN; Worthy MN; Lee B; Holbrook MR
J Gen Virol; 2010 Mar; 91(Pt 3):765-72. PubMed ID: 19889926
[TBL] [Abstract][Full Text] [Related]
14. The changing face of the henipaviruses.
Croser EL; Marsh GA
Vet Microbiol; 2013 Nov; 167(1-2):151-8. PubMed ID: 23993256
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.
Pallister J; Middleton D; Crameri G; Yamada M; Klein R; Hancock TJ; Foord A; Shiell B; Michalski W; Broder CC; Wang LF
J Virol; 2009 Nov; 83(22):11979-82. PubMed ID: 19759137
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions.
Glennon NB; Jabado O; Lo MK; Shaw ML
J Virol; 2015 Aug; 89(15):7550-66. PubMed ID: 25972557
[TBL] [Abstract][Full Text] [Related]
17. Henipavirus pathogenesis and antiviral approaches.
Mathieu C; Horvat B
Expert Rev Anti Infect Ther; 2015 Mar; 13(3):343-54. PubMed ID: 25634624
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model.
Zhu W; Zhang Z; He S; Wong G; Banadyga L; Qiu X
Antiviral Res; 2018 Mar; 151():39-49. PubMed ID: 29369776
[TBL] [Abstract][Full Text] [Related]
19. Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission.
Clayton BA; Wang LF; Marsh GA
Zoonoses Public Health; 2013 Feb; 60(1):69-83. PubMed ID: 22709528
[TBL] [Abstract][Full Text] [Related]
20. Animal challenge models of henipavirus infection and pathogenesis.
Geisbert TW; Feldmann H; Broder CC
Curr Top Microbiol Immunol; 2012; 359():153-77. PubMed ID: 22476556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
